Status:
COMPLETED
Transcranial Magnetic Stimulation for Treatment of Insomnia
Lead Sponsor:
University of Florida
Conditions:
Insomnia
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique that has been approved as a treatment of depression in patients that have not responded to a trial of one antidepr...
Detailed Description
Insomnia is a common clinical problem that affects about 25 million people in the US. Insomnia exacts health and economic consequences well beyond inadequate and non-restorative sleep. It increases he...
Eligibility Criteria
Inclusion
- Patients referred for evaluation and management of insomnia to our sleep disorders clinic will be offered enrollment in this study
- Patients must meet Diagnostic and Statistical Manual (DSM) IV criteria for Primary insomnia
- Aged 21-65 years to target relatively healthy adults
Exclusion
- Patients with co-morbid depression
- Substance abuse in last two weeks
- No Psychotropic medication changes 2 weeks before start of TMS treatment and no changes during the 3 week treatment period
- Patients with a major medical or psychiatric disorder that may be causing or contributing to insomnia: bipolar disorder, psychosis, anxiety disorders, dementia, seizure disorder and chronic pain
- Patients with ferromagnetic material in their head or within 30 cm of the coil will be excluded
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2021
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT02196025
Start Date
May 1 2015
End Date
July 21 2021
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF @ Shands
Gainesville, Florida, United States, 32610